A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Tonapofylline (Primary)
  • Indications Decompensated heart failure; Renal failure
  • Focus Adverse reactions
  • Acronyms TRIDENT-1
  • Most Recent Events

    • 02 Apr 2012 This trial has been suspended in (Czech Republic, Finland) as reported by European Clinical Trials Database record.
    • 02 Apr 2012 Actual initiation date is (25 Sep 2008) as reported by European Clinical Trials Database record
    • 03 Feb 2010 New source identified and integrated (Clinical Trials Registry - India).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top